MARJAN PHARMA GROUP
ABOUT MARJAN PHARMA GROUP


OUR FOUNDATION
Marjan Pharma Group was established in 2004 by its founder, Dr. Amer Marjan, building on his extensive knowledge and experience of the Iraqi pharmaceutical market and before establishing Marjan Pharma Group, Dr. Amer Marjan held several vital roles within the Ministry of Health and the Ministry of Industry in Iraq, including leadership of the pharmaceutical sector across Iraq.
Drawing on this extensive experience, Marjan Pharma Group was established with a strong commitment to regulatory compliance, professional ethics and, above all, patient safety. These principles continue to guide the company's decisions, operations, and partnerships.
Marjan Pharma Group has grown into a leading pharmaceutical distribution company in:
Iraq, with its operations and market reach extending to Jordan, Kuwait, and Libya, with further regional expansion planned for the future.
COMPANY MILESTONES
Our Growth Story Across the Region
2004 — IRAQ
2016 — JORDAN
2018 — KUWAIT
2023 — LIBYA
Marjan Pharma Group was established in Iraq, founding our regional footprint on deep market experience.
Strategic expansion into the Jordanian market, establishing key institutional health channels.
Commercial expansion into the Kuwaiti healthcare sector, strengthening partner networks.
Operational entry into the Libyan market, providing direct access to essential therapeutics.
OUR PURPOSE
Vision, Mission & Values
VISION
MISSION
VALUES
To be a leading and trusted pharmaceutical partner across the Middle East, connecting global healthcare companies with patients and healthcare markets through responsible and sustainable market access.
To provide reliable pharmaceutical market access and distribution solutions while maintaining the highest standards of regulatory compliance, quality, integrity and patient safety.
PATIENT SAFETY: We place patient well-being first.
INTEGRITY: Transparency and ethics.
COMPLIANCE: Upholding all laws.
PARTNERSHIP: Long-term trusted ties.
EXCELLENCE: Continuous operational quality.






STRATEGIC ADVANTAGE
We bridge international healthcare innovation with Middle Eastern pharmaceutical markets through proven local capabilities.
INSIGHT
GOVERNANCE
LOGISTICS
COMMITMENT
Regional Market Knowledge
Regulatory Expertise
Commercial & Distribution Reach
Long-Term Partnerships
Decades of direct operational experience navigating Middle Eastern healthcare markets, commercial dynamics, and local requirements.
Uncompromising standards in regulatory compliance, swift authorization pathways, and strict adherence to international safety laws.
Robust supply chain infrastructure, cold-chain integrity across every channel, and deep access to institutional and retail markets.
Building transparent, sustainable relationships with multinational healthcare leaders to deliver reliable market access.








